SmartGateVC portfolio companies TACTUN, Robin the Robot, by Expper Technologies and Vonova rocked among 7 other companies at #GlendaleTechWeek2024 Demo Day that we co-organized with the City of Glendale, CA! Thank you to the judges: Juan Saez - Founding Investor at Play Time, Armen Vartanian - Founder at Oceanview Capital Partners, Inc., Patrick Harmon Lopez - Principal at B Capital Group, Kenji (Ken) Funahashi - Partner at Wilson Sonsini Goodrich & Rosati, moaz ゼ H. - Founding Partner at mvmt ventures. Congratulations to TACTUN for winning?the top prize! Thank you to Wilson Sonsini Goodrich & Rosati for partnership. ? TACTUN is building the foundation for future autonomous machinery, enabling direct deployment of custom AI models to controllers. TACTUN’s no-code AI-powered industrial controller and app builder reduce development cycles by 5x for machinery manufacturers. With deep expertise in hardware and software, the team has a proven track record with Boeing, Lockheed Martin, ThermoFisher and other industry leaders. ? Robin the Robot, by Expper Technologies is a pioneering health tech company that developed Robin the Robot, a therapeutic companion providing essential mental health care to pediatric and geriatric facilities. Recognized as Time Magazine's Best Invention of the Year and awarded Fast Company’s Best Design Award, Robin is deployed in over 26 medical facilities, including UCLA Children’s Hospital and UMass Memorial Medical Center. Using evidence-based psychological tools and real-life feedback, Robin's character has been refined to resonate deeply with children and elderly, bringing them emotional support and positively impacting their health outcomes during medical treatments. ? Vonova is developing a minimally invasive endovascular platform to access the brain's surface without drilling through the skull. Initially targeting chronic subdural hematomas (cSDH) in the elderly for FDA pathway, it aims to reduce treatment from two anesthesia events to one, eliminating neurosurgery risks. cSDH treatment is projected to become the most common neurosurgical procedure by 2030, representing a $1.1 billion U.S. market. Cortical neuromodulation therapies for chronic pain, epilepsy, and other disorders are additional opportunities. Upon FDA approval, the technology also opens opportunities for minimally invasive brain-computer interface (BCI) use cases. Founded in 2022 by experts in endovascular devices and neurology, Vonova has secured two U.S. patents, demonstrated procedural feasibility with leading clinicians, established strategic collaborations - including one with Lawrence Livermore National Laboratory - and received the NIH Blueprint Seed Award.
-
-
-
-
-
+5
aimentalhealthadvisor.com AI fixes this (AI Mental Health Advisor) SmartGateVC highlights GlendaleTechWeek2024 Demo
Congrats Rafayel Ghasabyan !
Congrats!
on a mission to building healthier, happier, more productive communities ? @mvmtvc
5 个月it was an absolute delight to review these remarkable startups. congratulations to the winners!